In October 2016 United Kingdom Anti-Doping (UKAD) has reported an anti-doping rule violation against the Athlete Chinu Sandhu after her sample tested positive for the prohibited substance stanozolol.
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the National Anti-Doping Panel.
The Athlete did not challenge the test results and stated that the probable source of the prohibited substance is the supplement Myprotein he had used. He mentioned the supplement on the Doping Control Form and had researched the product on the internet before using. Because of the cost the Athlete did not conduct tests of the supplements nor offered these to UKAD to conduct these tests.
The Panel concludes that the Athlete has not proved to their comfortable satisfaction that the violation was unintentional because he did not establish that the prohibited substance entered his system through using a supplement from an apparently reputable supplier which turned out to be contaminated.
Therefore National Anti-Doping Panel decides on 27 February 2017 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 14 October 2016.
